Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 180

1.

Characterising deviation from treat-to-target strategies for early rheumatoid arthritis: the first three years.

Wabe N, Sorich MJ, Wechalekar MD, Cleland LG, McWilliams L, Lee A, Spargo L, Metcalf RG, Hall C, Proudman SM, Wiese MD.

Arthritis Res Ther. 2015 Mar 8;17:48. doi: 10.1186/s13075-015-0562-0.

2.

Synovial fluid and plasma n3 long chain polyunsaturated fatty acids in patients with inflammatory arthritis.

Moghaddami M, James M, Proudman S, Cleland LG.

Prostaglandins Leukot Essent Fatty Acids. 2015 Jun;97:7-12. doi: 10.1016/j.plefa.2015.02.005. Epub 2015 Mar 16.

PMID:
25817850
3.

Synovial fluid myeloid dendritic cells display important differences compared to monocyte-derived dendritic cells prepared in vitro.

Moghaddami M, James M, Whittle SL, Cleland LG.

Clin Transl Immunology. 2014 Aug 8;3(8):e23. doi: 10.1038/cti.2014.19. eCollection 2014 Aug.

4.

Multicentric myofibroblastic sarcoma.

Wechalekar MD, Ayres O, Farshid G, Clayer M, Cleland LG.

BMJ Case Rep. 2014 Nov 3;2014. pii: bcr2013201666. doi: 10.1136/bcr-2013-201666.

PMID:
25368122
5.

Appendicular skeletal muscle in hospitalised hip-fracture patients: development and cross-validation of anthropometric prediction equations against dual-energy X-ray absorptiometry.

Villani AM, Crotty M, Cameron ID, Kurrle SE, Skuza PP, Cleland LG, Cobiac L, Miller MD.

Age Ageing. 2014 Nov;43(6):857-62. doi: 10.1093/ageing/afu106. Epub 2014 Jul 21.

PMID:
25049262
6.

The rheumatoid arthritis susceptibility polymorphism PTPN22 C1858T is not associated with leflunomide response or toxicity.

Hopkins AM, O'Doherty CE, Foster DJ, Suppiah V, Upton RN, Spargo LD, Cleland LG, Proudman SM, Wiese MD.

J Clin Pharm Ther. 2014 Oct;39(5):555-60. doi: 10.1111/jcpt.12189. Epub 2014 Jul 8.

PMID:
25040563
7.

Pitfalls in the use of randomised controlled trials for fish oil studies with cardiac patients.

James MJ, Sullivan TR, Metcalf RG, Cleland LG.

Br J Nutr. 2014 Sep 14;112(5):812-20. doi: 10.1017/S0007114514001408. Epub 2014 Jun 16.

PMID:
24933212
8.

RE: Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial.

Cleland LG, Proudman SM, James MJ.

J Natl Cancer Inst. 2014 Apr;106(4):dju022. doi: 10.1093/jnci/dju022. Epub 2014 Mar 31. No abstract available.

9.

Pharmacogenomics of NAT2 and ABCG2 influence the toxicity and efficacy of sulphasalazine containing DMARD regimens in early rheumatoid arthritis.

Wiese MD, Alotaibi N, O'Doherty C, Sorich MJ, Suppiah V, Cleland LG, Proudman SM.

Pharmacogenomics J. 2014 Aug;14(4):350-5. doi: 10.1038/tpj.2013.45. Epub 2014 Jan 7.

PMID:
24394199
10.

Gemcitabine-induced radiation recall myositis in a patient with dermatomyositis.

Graf SW, Limaye VS, Cleland LG.

Int J Rheum Dis. 2014 Jul;17(6):696-7. doi: 10.1111/1756-185X.12233. Epub 2013 Nov 28. No abstract available.

PMID:
24283707
11.

U-shaped relationship between tissue docosahexaenoic acid and atrial fibrillation following cardiac surgery.

Metcalf RG, Skuladottir GV, Indridason OS, Sullivan TR, Bjorgvinsdottir L, Sanders P, Arnar DO, Gibson RA, Heidarsdottir R, Cleland LG, Palsson R, Farquharson AL, Young GD, James MJ.

Eur J Clin Nutr. 2014 Jan;68(1):114-8. doi: 10.1038/ejcn.2013.215. Epub 2013 Oct 30.

PMID:
24169465
12.

Epidemiology of biopsy-proven giant cell arteritis in South Australia.

Dunstan E, Lester SL, Rischmueller M, Dodd T, Black R, Ahern M, Cleland LG, Roberts-Thomson P, Hill CL.

Intern Med J. 2014 Jan;44(1):32-9. doi: 10.1111/imj.12293.

PMID:
24118799
13.

Fish oil in recent onset rheumatoid arthritis: a randomised, double-blind controlled trial within algorithm-based drug use.

Proudman SM, James MJ, Spargo LD, Metcalf RG, Sullivan TR, Rischmueller M, Flabouris K, Wechalekar MD, Lee AT, Cleland LG.

Ann Rheum Dis. 2015 Jan;74(1):89-95. doi: 10.1136/annrheumdis-2013-204145. Epub 2013 Sep 30.

PMID:
24081439
14.

Molecular basis for differential elongation of omega-3 docosapentaenoic acid by the rat Elovl5 and Elovl2.

Gregory MK, Cleland LG, James MJ.

J Lipid Res. 2013 Oct;54(10):2851-7. doi: 10.1194/jlr.M041368. Epub 2013 Jul 21.

15.

Fish oil administration in older adults with cardiovascular disease or cardiovascular risk factors: is there potential for adverse events? A systematic review of the literature.

Villani AM, Crotty M, Cleland LG, James MJ, Fraser RJ, Cobiac L, Miller MD.

Int J Cardiol. 2013 Oct 9;168(4):4371-5. doi: 10.1016/j.ijcard.2013.05.054. Epub 2013 Jun 3. Review. No abstract available.

PMID:
23742929
16.

Prostaglandin D(2) in inflammatory arthritis and its relation with synovial fluid dendritic cells.

Moghaddami M, Ranieri E, James M, Fletcher J, Cleland LG.

Mediators Inflamm. 2013;2013:329494. doi: 10.1155/2013/329494. Epub 2013 May 7.

17.

Fish oil administration in older adults: is there potential for adverse events? A systematic review of the literature.

Villani AM, Crotty M, Cleland LG, James MJ, Fraser RJ, Cobiac L, Miller MD.

BMC Geriatr. 2013 May 1;13:41. doi: 10.1186/1471-2318-13-41. Review.

18.

Association of DHODH haplotype variants and response to leflunomide treatment in rheumatoid arthritis.

O'Doherty C, Schnabl M, Spargo L, Cleland LG, James M, Proudman SM, Wiese MD.

Pharmacogenomics. 2012 Sep;13(12):1427-34. doi: 10.2217/pgs.12.118.

PMID:
22966891
19.

Polymorphisms in cytochrome P450 2C19 enzyme and cessation of leflunomide in patients with rheumatoid arthritis.

Wiese MD, Schnabl M, O'Doherty C, Spargo LD, Sorich MJ, Cleland LG, Proudman SM.

Arthritis Res Ther. 2012 Jul 12;14(4):R163. doi: 10.1186/ar3911.

20.

Osteoarthritis. Omega-3 fatty acids and synovitis in osteoarthritic knees.

Cleland LG, James MJ.

Nat Rev Rheumatol. 2012 Apr 17;8(6):314-5. doi: 10.1038/nrrheum.2012.60. No abstract available.

PMID:
22508432
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk